| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |